94 related articles for article (PubMed ID: 34699320)
1. E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375.
Li P; Lv H; Wu Y; Xu K; Xu M; Ma Y
Bioengineered; 2021 Dec; 12(2):10047-10062. PubMed ID: 34699320
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma.
Chen W; Wang L; Li X; Zhao C; Shi L; Zhao H; Huang C
Cell Death Dis; 2021 Aug; 12(9):806. PubMed ID: 34429400
[TBL] [Abstract][Full Text] [Related]
3. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway.
Liu R; Lu Y; Li J; Yao W; Wu J; Chen X; Huang L; Nan D; Zhang Y; Chen W; Wang Y; Jia Y; Tang J; Liang X; Zhang H
Cell Death Dis; 2024 Apr; 15(4):291. PubMed ID: 38658569
[TBL] [Abstract][Full Text] [Related]
5. miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation.
Wen J; Hu Y; Liu Q; Ling Y; Zhang S; Luo K; Xie X; Fu J; Yang H
EBioMedicine; 2018 Nov; 37():110-124. PubMed ID: 30361064
[TBL] [Abstract][Full Text] [Related]
6. AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway.
Li X; Dong H; Zheng Y; Ding S; Li Y; Li H; Huang H; Zhong C; Xie T; Xu Y
Mol Cell Probes; 2023 Dec; 72():101939. PubMed ID: 37879503
[TBL] [Abstract][Full Text] [Related]
7. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y
Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756
[TBL] [Abstract][Full Text] [Related]
8. COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway.
Hu J; Li P; Dan Y; Chen Z; Lu Y; Chen X; Yan S
Ann Surg Oncol; 2024 May; 31(5):3502-3512. PubMed ID: 38429534
[TBL] [Abstract][Full Text] [Related]
9. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
[TBL] [Abstract][Full Text] [Related]
10. NUPR1 induces autophagy and promotes the progression of Esophageal squamous cell carcinoma via the MAPK-mTOR pathway.
Ren S; Chen Y; Wang Q; Song L; Xin Z; Shi M; Liu X
Pathol Res Pract; 2024 May; 257():155323. PubMed ID: 38653091
[TBL] [Abstract][Full Text] [Related]
11. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of esophageal carcinoma development in miR-31 knockout rats.
Fong LY; Taccioli C; Palamarchuk A; Tagliazucchi GM; Jing R; Smalley KJ; Fan S; Altemus J; Fiehn O; Huebner K; Farber JL; Croce CM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6075-6085. PubMed ID: 32123074
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma.
Huang L; Wang Y; Chen J; Wang Y; Zhao Y; Wang Y; Ma Y; Chen X; Liu W; Li Z; Zhao L; Shan B; Dong X; Li D; Shao S; Song Y; Zhan Q; Liu X
Cell Death Dis; 2019 Jul; 10(7):513. PubMed ID: 31273188
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-196a-5p facilitates the onset and progression via targeting ITM2B in esophageal squamous cell carcinoma.
Xian D; Yang S; Liu Y; Liu Q; Huang D; Wu Y
Pathol Int; 2024 Mar; 74(3):129-138. PubMed ID: 38289121
[TBL] [Abstract][Full Text] [Related]
15. Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway.
Qiao Z; Dai C; Wang Z; Wang Z; Wang Z; Zhang T; Niu W; Ma X
Thorac Cancer; 2022 Apr; 13(8):1117-1125. PubMed ID: 35238170
[TBL] [Abstract][Full Text] [Related]
16. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
Wang C; Li Y; Wang L; Han Y; Gao X; Li T; Liu M; Dai L; Du R
Br J Cancer; 2024 May; 130(11):1770-1782. PubMed ID: 38600327
[TBL] [Abstract][Full Text] [Related]
17. Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt pathway activation.
Du R; Xiao N; Han L; Guo K; Li K; Chen Z; Zhang H; Zhou Z; Huang Y; Zhao X; Bian H
Sci Rep; 2024 Apr; 14(1):9167. PubMed ID: 38649770
[TBL] [Abstract][Full Text] [Related]
18. BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation.
Zhang P; Zhang W; Wang X; Li L; Lin Y; Wu N; Mao R; Lin J; Kang M; Ding C
Cancer Lett; 2024 Jun; 591():216874. PubMed ID: 38636894
[TBL] [Abstract][Full Text] [Related]
19. STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma.
Wang L; Zhao QF; Yang BB; Liang HJ; Zhang XE; Zhang XY; Yang WJ; Guo ZY; Xu X; Tian F; Wu QH
Acta Oncol; 2023 Dec; 62(12):1757-1766. PubMed ID: 37738252
[TBL] [Abstract][Full Text] [Related]
20. [Not Available].
Liu L; Chen Y; Zhang T; Cui G; Wang W; Zhang G; Li J; Zhang Y; Wang Y; Zou Y; Ren Z; Xue W; Sun R
Adv Sci (Weinh); 2024 May; 11(20):e2302379. PubMed ID: 38566431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
